2,817
Views
11
CrossRef citations to date
0
Altmetric
Review

Efficacy and safety of anti-PD-1/PD-L1 combinations versus standard of care in cancer: a systematic review and meta-analysis.

, , , , &
Article: 1878599 | Received 18 Nov 2020, Accepted 15 Jan 2021, Published online: 23 Feb 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.